Enhancement of complement-mediated lysis by a peptide derived from SCR 13 of complement factor H

Area of Science:

• Immunology
• Complement System Biology

Background:

• Complement factor H (fH) is a key regulator of the complement system, preventing damage to host cells.
• Understanding fH's regulatory mechanisms is crucial for controlling complement-mediated inflammatory and lytic responses.

Purpose of the Study:

• To investigate the impact of fH depletion on complement-mediated lysis of antibody-sensitized erythrocytes.
• To explore the functional activity of a specific fH-derived peptide (pepAred) on complement activation and cell lysis.

Main Methods:

• Depletion of fH from normal human serum (NHS).
• Assessing erythrocyte lysis in the presence and absence of fH and its derived peptides.
• Utilizing FACS analysis and radio-immuno assay to quantify C3 fragments and fH binding.
• Investigating the effect of pepAred on fH/fI-mediated cleavage of C3b.

Main Results:

• fH depletion significantly increased complement-mediated lysis of antibody-sensitized sheep and human erythrocytes.
• A specific fH-derived peptide (pepAred) enhanced complement-mediated lysis of human erythrocytes.
• PepAred demonstrated direct cell binding and interfered with fH-cell interactions, increasing C3 fragment deposition and reducing fH levels on cells.
• PepAred inhibited fH and factor I-mediated cleavage of C3b.

Conclusions:

• A peptide derived from complement factor H can enhance complement-mediated lysis.
• This fH-derived peptide exhibits pro-lytic activity, distinct from fH's protective role.
• Further research into fH peptides may reveal novel therapeutic strategies for complement-related disorders.